CAB and RPV, CAB plus RPV, Cabenuva kit, cabotegravir extended-release injectable suspension and rilpivirine extended-release injectable suspension
Integrase Strand Transfer Inhibitor (cabotegravir)
Non-Nucleoside Reverse Transcriptase Inhibitor (rilpivirine)
Molecular Weight: 405.3553
Molecular Weight: 366.4262
FDA label informationFDA label information
Several FDA-approved drug labels may be available for cabotegravir / rilpivirine. Clinical Info provides the following link to the DailyMed drug label solely as an example of the labels available for cabotegravir / rilpivirine. Inclusion or absence of a drug label link on the Clinical Info site does not imply endorsement or lack thereof by Clinical Info. Search DailyMed or Drugs@FDA to access more information on cabotegravir / rilpivirine, including additional drug labels and any generic equivalents.